Prostate Adenocarcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Recruiting
  • Prostate Cancer
  • +2 more
  • TULSA Procedure
  • West Hills, California
  • +4 more
2022-04-06
Apr 6, 2022
U
Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Aurora, Colorado
  • +1 more
2022-04-05
Apr 5, 2022
U
Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-04-04
Apr 4, 2022
E
Recruiting
  • Metastatic Prostate Cancer
  • Prostate Adenocarcinoma
  • Tucson, Arizona
  • +232 more
2022-03-28
Mar 28, 2022
A
Recruiting
  • Prostate Adenocarcinoma
  • Niraparib Pill
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2022-03-29
Mar 29, 2022
W
Recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Interview
  • Questionnaire Administration
  • Phoenix, Arizona
  • +324 more
2022-03-29
Mar 29, 2022
N
Terminated
  • Prostate Cancer
  • +6 more
  • NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension
  • Tampa, Florida
  • +3 more
2022-03-02
Mar 2, 2022
J
Active, not recruiting
  • Prostate Cancer
  • +3 more
  • Stereotactic Body Radiation Therapy with Integrated Boost
  • Birmingham, Alabama
    Hazelrig-Salter Radiation Oncology Center
2022-03-25
Mar 25, 2022
R
Recruiting
  • Prostate Adenocarcinoma
  • +9 more
  • Angiogram
  • +3 more
  • San Francisco, California
    University of California San Francisco
2022-03-24
Mar 24, 2022
U
Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-22
Mar 22, 2022
U
Not yet recruiting
  • Prostate Adenocarcinoma
  • Salt Lake City, Utah
    Huntsman Cancer Institute at University of Utah
2022-03-16
Mar 16, 2022
C
Recruiting
  • Prostate Adenocarcinoma
  • Clermont-Ferrand, France
  • +5 more
2022-03-14
Mar 14, 2022
P
Recruiting
  • Prostate Cancer
  • Prostate Adenocarcinoma
  • Radical Prostatectomy
  • TULSA Procedure
  • Tarzana, California
  • +6 more
2022-03-11
Mar 11, 2022
U
Not yet recruiting
  • Prostate Cancer
  • +3 more
  • Abiraterone Oral Tablet
  • +3 more
  • (no location specified)
2022-03-02
Mar 2, 2022
U
Active, not recruiting
  • Prostate Cancer
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan
2022-03-10
Mar 10, 2022
E
Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • 3-Dimensional Conformal Radiation Therapy
  • +11 more
  • Duarte, California
  • +35 more
2022-03-09
Mar 9, 2022
U
Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • +6 more
  • Computed Tomography
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-07
Mar 7, 2022
U
Active, not recruiting
  • Prostate Adenocarcinoma
  • F-18 fluciclovine-PET/CT scan
  • Tucson, Arizona
    University of Arizona
2022-03-07
Mar 7, 2022
A
Active, not recruiting
  • Prostate Adenocarcinoma
  • Gallium Ga 68-labeled GRPR Antagonist BAY86-7548
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
2022-03-02
Mar 2, 2022
L
Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • San Francisco, California
  • +1 more
2022-02-14
Feb 14, 2022
S
Not yet recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • radium-223
  • Bipolar Androgen Therapy (BAT)
  • Baltimore, Maryland
  • +1 more
2022-03-02
Mar 2, 2022
S
Suspended
  • Prostate Adenocarcinoma
  • Obesity, Morbid
  • Bead Block 300-500 um
  • +2 more
  • Baltimore, Maryland
    Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive C
2022-02-14
Feb 14, 2022
M
Recruiting
  • Prostate Adenocarcinoma
  • Basking Ridge, New Jersey
  • +5 more
2022-02-28
Feb 28, 2022
N
Active, not recruiting
  • Male Breast Carcinoma
  • +7 more
  • Stereotactic Body Radiation Therapy (SBRT)
  • Birmingham, Alabama
  • +77 more
2022-02-28
Feb 28, 2022
M
Active, not recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022